The good, the bad and the ugly of the new treatments for hepatitis C virus
- PMID: 25152995
The good, the bad and the ugly of the new treatments for hepatitis C virus
Comment on
-
Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals.Hepatology. 2014 Jul;60(1):37-45. doi: 10.1002/hep.27151. Epub 2014 May 14. Hepatology. 2014. PMID: 24677184 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
